A Phase 1/2 Study of ABI-009 (Nab-Rapamycin) With Pazopanib (VOTRIENT) in Patients With Advanced Nonadipocytic Soft-Tissue Sarcomas
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 21 Feb 2019
At a glance
- Drugs Pazopanib (Primary) ; Sirolimus (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 14 Feb 2019 Planned initiation date changed from 25 Jan 2019 to 1 Apr 2019.
- 15 Nov 2018 Planned initiation date changed from 25 Oct 2018 to 25 Jan 2019.
- 12 Sep 2018 New trial record